Teleflex Incorporated (NYSE:TFX) Receives Average Recommendation of “Hold” from Analysts

Shares of Teleflex Incorporated (NYSE:TFX) have been given a consensus rating of “Hold” by the ten brokerages that are currently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $146.00.

TFX has been the subject of a number of recent research reports. Truist Financial reaffirmed a “hold” rating and issued a $143.00 target price (up from $135.00) on shares of Teleflex in a research note on Monday, May 11th. Raymond James Financial reissued an “outperform” rating and set a $150.00 price target on shares of Teleflex in a research report on Friday, May 8th. Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $140.00 to $160.00 in a report on Monday, June 8th. Mizuho set a $140.00 price objective on shares of Teleflex in a research report on Friday, May 8th. Finally, Bank of America raised shares of Teleflex from an “underperform” rating to a “neutral” rating and set a $135.00 target price on the stock in a research note on Monday, April 13th.

Teleflex Price Performance

TFX stock opened at $134.09 on Friday. The company has a debt-to-equity ratio of 0.82, a current ratio of 2.55 and a quick ratio of 2.03. The business has a 50 day simple moving average of $130.04 and a 200-day simple moving average of $119.69. The firm has a market capitalization of $5.94 billion, a PE ratio of -5.88, a price-to-earnings-growth ratio of 0.96 and a beta of 0.82. Teleflex has a 1 year low of $100.18 and a 1 year high of $139.67.

Teleflex (NYSE:TFX) last announced its quarterly earnings data on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.18. The firm had revenue of $548.30 million for the quarter, compared to the consensus estimate of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The firm’s revenue was up 32.3% compared to the same quarter last year. During the same quarter last year, the business posted $1.44 earnings per share. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. Equities research analysts anticipate that Teleflex will post 6.7 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Monday, May 25th were issued a $0.34 dividend. The ex-dividend date was Friday, May 22nd. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. Teleflex’s dividend payout ratio is currently -5.96%.

Institutional Investors Weigh In On Teleflex

Several hedge funds and other institutional investors have recently added to or reduced their stakes in TFX. Versant Capital Management Inc grew its holdings in shares of Teleflex by 573.4% during the 2nd quarter. Versant Capital Management Inc now owns 431 shares of the medical technology company’s stock worth $55,000 after purchasing an additional 367 shares during the period. Glenmede Trust Co. NA raised its holdings in Teleflex by 42.1% in the 1st quarter. Glenmede Trust Co. NA now owns 6,867 shares of the medical technology company’s stock valued at $821,000 after buying an additional 2,036 shares during the period. Bank of America Corp DE raised its holdings in Teleflex by 6.4% in the 1st quarter. Bank of America Corp DE now owns 445,958 shares of the medical technology company’s stock valued at $53,341,000 after buying an additional 27,004 shares during the period. Janus Henderson Group PLC lifted its position in Teleflex by 1.1% in the first quarter. Janus Henderson Group PLC now owns 4,291,311 shares of the medical technology company’s stock valued at $513,281,000 after buying an additional 45,199 shares during the last quarter. Finally, Irenic Capital Management LP acquired a new position in Teleflex in the first quarter valued at about $104,061,000. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Company Profile

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.